# AgomAb Therapeutics NV: Form 6-K, filed Feb 9, 2026

- Company: [AgomAb Therapeutics NV](/companies/agmb.md) (CIK 2020932)
- Form: 6-K
- Filed: 2026-02-09
- Accepted by EDGAR: Feb 9, 2026, 16:18 ET
- Period: 2026-02-09
- Accession: 0001104659-26-012080
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2020932/000110465926012080/tm2415594d20_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2020932/000110465926012080/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2020932/000110465926012080/tm2415594d20_6k.htm

Filed Feb 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-012080. Last ingested by Listed: Nov 6, 2026, 11:21 ET. No prices; not investment advice.